Emtora Biosciences   Report issue

For profit Phase 2
Founded: San Antonio TX United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2018
NCT03618355
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Rapamycin Holdings Inc. | Rapamycin Holdings, Inc. dba Emtora Biosciences